Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Applied Genetic Tech (NQ: AGTC )

5.960 USD +0.150 (+2.58%)
Streaming Delayed Price Updated: 7:06 AM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,318
Open 5.810
Bid (Size) 5.900 (9)
Ask (Size) 6.000 (4)
Prev. Close 5.810
Today's Range 5.690 - 6.190
52wk Range 2.290 - 9.670
Shares Outstanding 18,110,536
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AGTC to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021
From GlobeNewswire News Releases

Performance

YTD
+37.33%
+37.33%
1 Month
+50.89%
+50.89%
3 Month
+23.65%
+23.65%
6 Month
+15.95%
+15.95%
1 Year
+23.65%
+23.65%

More News

Read More
AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021
From GlobeNewswire News Releases
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2020
From GlobeNewswire News Releases
AGTC Executives Awarded First Place in the BioProcess International Reader’s Choice Awards, Cell & Gene Therapies Category
From GlobeNewswire News Releases
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 11, 2021
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tags Benzinga AKER After/Hours Center
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags CRTX AVRO Market News
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tags LCI RWLK Benzinga
From Benzinga
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Tags OYST IMUX PCSA
From Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Tags SEEL RHHBY Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.